ArticlePloS one2018

Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD).

Qiang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.